Lates News

Eli Lilly's oral weight loss drug in the United States has been approved, putting pressure on competitors Novo Nordisk. Eli Lilly's drug has been approved to help people lose weight or maintain previous weight loss results. The oral drug from Eli Lilly has been approved to help patients lose weight or maintain previous weight loss results. This review took less than four months thanks to a new project launched by the Food and Drug Administration (FDA) aiming to accelerate the market entry of drugs that meet national priorities, provide innovative therapies, or meet unmet medical needs. Eli Lilly is quickly catching up with Novo Nordisk, whose weight loss drug has been in high demand since its approval in December of last year. Eli Lilly has produced billions of doses of Foundayo to ensure quick market entry. Wall Street analysts predict that sales of this drug could reach $18 billion by 2030.